Publications
ANAPHYLAXIS: Revision of the Brighton collaboration case definition.
AUTHORS: Gold MS, Amarasinghe A, Greenhawt M, Kelso JM, Kochhar S, Yu-Hor Thong B, Top KA, Turner PJ, Worm M, Law B.
PUBLICATION: Vaccine
PUBLICATION DATE: 6-Apr-23
ANOSMIA: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
AUTHORS: Yi-Chun CL, Munoz FM, Izurieta HS, Tamborska AA, Solomon T, Law B, & Chhabra N.
PUBLICATION: Vaccine
PUBLICATION DATE: 10-Mar-23
Maternal Immunization Working Group Meeting Report (November, 2022).
AUTHORS: Maternal Immunzation Working Group Members
PUBLICATION DATE: 7-Mar-23
THROMBOSIS AND THROMBOEMBOLISM: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
AUTHORS: Gollamudi J, Sartain SE, Navaei AH, Aneja S, Kaur Dhawan P, Tran D, Joshi J, Gidudu J, Gollamudi J, Chiappini E, Varricchio F, Law B, Munoz FM.
PUBLICATION: Vaccine
PUBLICATION DATE: 19-Oct-22
Assessing the Brighton Collaboration Case Definition of Sensorineural Hearing Loss in Ghana.
AUTHORS: Bukari I, Huang W, Issahalq DM.
PUBLICATION: The American Journal of Tropical Medicine and Hygiene
PUBLICATION DATE: 17-Oct-22
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.
AUTHORS: Folegatti P, Jenkin D, Morris S, Gilbert S, Kim D, Robertson JS, Smith ER, Martin E, Gurwith M, Chen RT.
PUBLICATION: Vaccine
PUBLICATION DATE: 19-Aug-22
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).
AUTHORS: Leav B, Straus W, White P, Leav A, Gaines T, Maggiacomo G, Kim D, Smith ER, Gurwith M, Chen RT.
PUBLICATION: Vaccine
PUBLICATION DATE: 19-Aug-22
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus.
AUTHORS: Hernandez LM, Sumathy K, Sahastrabuddhe S, Excler JL, Kochhar S, Smith ER, Gurwith M, Chen RT.
PUBLICATION: Vaccine
PUBLICATION DATE: 19-Aug-22
MYOCARDITIS AND PERICARDITIS: case definition and guidelines for data collection, analysis, and presentation 2 of immunization safety data.
AUTHORS: Sexson Tejtel K, Munoz FM, Al-Ammouri I, Savorgnan F, Guggilla R, Khuri-Bulos N, Phillips L, Engler RJM
PUBLICATION: Vaccine
PUBLICATION DATE: 1-Mar-22
Brighton Collaboration Case Finding Definition of Thrombosis with Thrombocytopenia Syndrome (TTS).
PUBLICATION DATE: 11-Nov-21
Benefit-Risk Assessment of VAccines by TechnolOgy Working Group BRAVATO, ex-V3SWG). A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses.
AUTHORS: Eldridge JH, Egan MA, Matassov D, Hamm S, Hermida L, Chen T, Tremblay M, Sciotto-Brown S, Xu R, Dimitrov A, Smith ER, Gurwith M, Chen RT.
PUBLICATION: Vaccine
PUBLICATION DATE: 7-Sept-21
Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines | August 2021.
AUTHORS: Willame C, Dodd C, Gini R, Durán CE, Thomsen RM, Wang L, Gedebjerg A, Kahlert J, Ehrenstein V, Bartolini C, Droz C, Moore N, Haug U, Schink T, Diez-Domingo J, Mira-Iglesias A, Vergara-Hernández C, Carreras JJ, Villalobos F, Pallejà M, Aragón M, Perez-Gutthann S, Arana A, Giaquinto C, Barbieri E, Stona L, Huerta C, Pallejà M, Aragón M, García Poza P, de Burgos A, Martínez-González M, Souverein P, Gardarsdottir H, Siiskonen SJ, Weibel D, Mahy P, Klungel O, Sturkenboom MCJM.
PUBLICATION DATE: 25-Aug-21
Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
AUTHORS: Serazin NA, Edem B, Williams SR, Ortiz JR, Kawade A, Das MK, Šubelj M, Edwards KM, Parida SK, Wartel TA, Munoz FM, Bastero P.
PUBLICATION: Vaccine
PUBLICATION DATE: 21-May-21
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
AUTHORS: Vogel TP, Top KA, Karatzios C, Hilmers DC, Tapia LI, Moceri P, Giovannini-Chami L, Wood N, Chandler RE, Klein NP, Schlaudecker EP, Poli MC, Muscal E, Munoz FM.
PUBLICATION: Vaccine
PUBLICATION DATE: 21-May-21
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
AUTHORS: Munoz FM, Cramer JP, Dekker CL, Dudley MZ, Graham BS, Gurwith M, Law B, Perlman S, Polack FP, Spergel JM, Van Braeckel E, Ward BJ, Didierlaurent AM, Lambert PH.
PUBLICATION: Vaccine
PUBLICATION DATE: 21-May-21
The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
AUTHORS: Black SB, Law B, Chen RT, Dekker CL, Sturkenboom M, Huang WT, Gurwith M, Poland G.
PUBLICATION: Vaccine
PUBLICATION DATE: 6-May-21
How to ensure we can track and trace global use of COVID-19 vaccines?
AUTHORS: Vander Stichele RH, Hay C, Fladvad M, Sturkenboom MCJM, Chen RT.
PUBLICATION: Vaccine
PUBLICATION DATE: 8-Jan-21
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
AUTHORS: Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, Subbarao K, Cramer JP.
PUBLICATION: Vaccine
PUBLICATION DATE: 26-Jun-20
Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
AUTHORS: Carol Liu YC, Ibekwe T, Kelso JM, Klein NP, Shehu N, Steuerwald W, Aneja S, Dudley MZ, Garry R, Munoz FM; Brighton Collaboration SNHL Working Group.
PUBLICATION: Vaccine
PUBLICATION DATE: 19-Jun-20
